NOVOMEDIX LLC has a total of 36 patent applications. It decreased the IP activity by 85.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, China and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are KALVINSH IVARS, UNIV BEIJING PEKING WBL BIOTECH CO LTD and YANGSEN BIOTECHNOLOGY CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | China | 5 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | EPO (European Patent Office) | 3 | |
#6 | Mexico | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | New Zealand | 2 | |
#9 | Singapore | 2 | |
#10 | South Africa | 2 | |
#11 | Republic of Korea | 1 | |
#12 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Fung Leah M | 31 |
#2 | Chan Kyle W H | 30 |
#3 | Swindlehurst Cathy A | 30 |
#4 | Sullivan Robert W | 20 |
#5 | Kyle W H Chan | 5 |
#6 | Leah M Fung | 4 |
#7 | Cathy A Swindlehurst | 4 |
#8 | Robert W Sullivan | 2 |
#9 | Swindelhurst Cathy A | 1 |
#10 | Chan Kyle | 1 |
Publication | Filing date | Title |
---|---|---|
AU2017356926A1 | Nitrite salts of 1, 1-dimethylbiguanide, pharmaceutical compositions, and methods of use | |
NZ630786A | Substituted biaryl sulfonamides and the use thereof | |
CN104860907A | Furanyl compounds and the use thereof |